Establishing a network for Familial Alzheimer's Disease in China
Official title: A Multi-center Longitudinal Cohort Study of Familial Alzheimer's Disease in China
Run by Capital Medical University · NCT03657732 · Data updated 2026-11-12
This study is trying to build a network in China to better understand Familial Alzheimer's Disease by collecting information about families, genetics, and the disease's progression.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40000 (estimated) |
| Sponsor | Capital Medical University Academic / other |
| Locations | 65 sites (Hefei, Anhui and 64 other locations) |
| Status | Recruiting |
| Started | January 10, 2005 |
| Main results expected | January 1, 2038 |
| Study ends | January 1, 2038 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT03657732 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals from families with a history of Alzheimer's Disease, specifically those with at least two first-degree relatives affected by the condition.
✕Probably not a fit
Patients without a familial history of Alzheimer's Disease or those who are bedridden may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to create and enhance a nationwide network focused on Familial Alzheimer's Disease (FAD) in China. By gathering extensive data on family demographics, genetics, neuropsychology, neuroimaging, and biomarkers, the study seeks to clarify the genetic and clinical characteristics of FAD. It will also investigate the epidemiology of the disease across different demographics and regions in China. The project will involve regular follow-ups and sample collections to monitor disease progression and identify potential early diagnostic biomarkers.
Why it matters
Potential benefit: If successful, this study could lead to improved clinical diagnosis and treatment options for patients with Familial Alzheimer's Disease.
How similar studies have gone: Other studies focusing on familial Alzheimer's Disease have shown promise, but this specific approach in the Chinese population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Familial Alzheimer's disease group Inclusion criteria: 1. Written informed consent obtained from the participant or a legal guardian prior to any study-related procedures; 2. At least two first-degree relatives in a family have AD (clinically or by testing),and at least 3 out of 2 generations are patients; 3. At least one family member with normal cognitive function (the age should be greater than the average age of onset of the family); 4. Pedigrees carrying FAD pathogenic genes (APP/PSEN1/PSEN2); 5. People in this family \>18 years old can be recruited; 6. Participant is cognitively normal or demented but not reaching bedridden level; 7. Participants are able to provide two reliable informants who can provide clinical information; 8. Dementia is diagnosed according to the criteria described by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-R ); 9. The diagnosis of AD is made using the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA ) or National Institute on Aging and the Alzheimer's Association (NIA-AA) criteria ; 10. The diagnosis of MCI is made according to Petersen criteria and the classification is according to the method of Lopez et al. Exclusion criteria: 1. Dementia caused by other factors such as depression, other psychiatric illnesses, thyroid dysfunction, encephalitis, multiple sclerosis, brain trauma, brain tumor, syphilis, acquired immunodeficiency syndrome (AIDS), Creutzfeldt-Jakob disease and other types of dementias such as vascular dementia (VaD), frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), and Parkinson's dementia (PDD); 2. MRI and laboratory tests do not support or rule out a diagnosis of AD; 3. Severe circulatory, respiratory, urinary, digestive, hematopoietic diseases (such as unstable angina, uncontrollable asthma, active gastric bleeding) and cancer; 4. Participant has severe psychiatric illness or severe dementia that would interfere in completing initial and follow-up clinical assessments; 5. Participant has a history of alcoholism or drug abuse; 6. Pregnant or lactating women; 7. No reliable informant; 8. Lumbar puncture exclusion criteria:coagulation disorders or platelet counts \< 100,000 cells/μL, lumbar surgery within the last 6 months prior to lumbar puncture that interferes with anatomy of the inter-vertebral spaces, History of chronic or repeated CSF leakage following previous LP(s); 9. MRI Exclusion Criteria: electronic and magnetic metal implants such as pacemakers, artificial heart valve, metal prosthesis, metal joint, etc.; metallic foreign body in the eye; aneurysm clips in the brain. Normal control group Inclusion criteria: 1. Aged 18 (inclusive) or above; 2. Normal MMSE and MoCA evaluations. MMSE\>19 points for illiteracy, \>24 points for those educated less than 7 years, \>27 points for those educated equal to or more than 7 years. MoCA\>13 points for illiteracy, \>19 points for those educated less than 7 years, \>24 points for those educated equal to or more than 7 years. Exclusion criteria: 1. Subjects with abnormal MMSE or MoCA scores; 2. Subjects with a history of cerebral infarction, traumatic brain injury or related manifestations in MRI; 3. Other neurological diseases that can cause brain dysfunction (such as depression, brain tumor, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal intracranial pressure hydrocephalus, etc.); 4. Other systemic diseases that can cause cognitive impairment (such as liver, renal and thyroid insufficiency, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.); 5. Mental and neurodevelopmental retardation; 6. Suffering from a disease that cannot be combined with a cognitive examination; 7. Contraindications to MRI; 8. Refuse to draw blood; 9. Refuse to sign the informed consent at baseline.
Where it's running
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China Recruiting -
Beijing Geriatric Hospital
Changping, Beijing Municipality, China Recruiting -
Beijing Chao Yang Hospital
Chaoyang, Beijing Municipality, China Recruiting -
China-Japan Friendship Hospital
Chaoyang, Beijing Municipality, China Recruiting -
Dongfang Hospital Affiliated to Beijing University of Chinese Medicine
Fengtai, Beijing Municipality, China Recruiting -
Chinese PLA General Hospital
Haidian, Beijing Municipality, China Recruiting
Show 44 more locations
-
Fu Xing Hospital, Capital Medical University
Haidian, Beijing Municipality, China Recruiting -
Peking University Third Hospital
Haidian, Beijing Municipality, China Recruiting -
Peking Union Medical College Hospital
Xicheng, Beijing Municipality, China Recruiting -
Peking University First Hospital
Xicheng, Beijing Municipality, China Recruiting -
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Yuzhong, Chongqing Municipality, China Recruiting -
The Second Affiliated Hospital of Chongqing Medical University
Yuzhong, Chongqing Municipality, China Recruiting -
Fujian Medical University Union Hospital
Fujian, Guangdong, China Recruiting -
Guangzhou Psychiatric Hospital
Guangzhou, Guangdong, China Recruiting -
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zhongshan, Guangdong, China Recruiting -
First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China Recruiting -
The Affiliated Hospital Of Guizhou Medical University
Guiyang, Guizhou, China Recruiting -
Handan Central Hospital
Handan, Hebei, China Recruiting -
First Hospital of Shijiazhuang City
Shijiazhuang, Hebei, China Recruiting -
Tangshan Worker's Hospital
Tangshan, Hebei, China Recruiting -
Hebei General Hospital
Zhijiazhuang, Hebei, China Recruiting -
First Affiliated Hospital of Harbin Medical University
Haerbin, Heilongjiang, China Recruiting -
Kaifeng Central Hospital
Kaifeng, Henan, China Recruiting -
Henan Provincial People's Hospital
Zhengzhou, Henan, China Recruiting -
People's Hospital of Zhengzhou
Zhengzhou, Henan, China Recruiting -
People's Hospital Affiliated Hubei Medical University
Wuhan, Hubei, China Recruiting -
Tongji Hospital
Wuhan, Hubei, China Recruiting -
The Third Xiangya Hospital of Central South University
Wuhan, Hunan, China Recruiting -
Wuhan University Zhongnan Hospital
Wuhan, Hunan, China Recruiting -
Xiangya Hospital of Central South University
Wuhan, Hunan, China Recruiting -
Nantong University Affiliated Hospital
Nantong, Jiangsu, China Recruiting -
Subei People's Hospital of Jiangsu
Subei, Jiangsu, China Recruiting -
Mineral General Hospital, Xuzhou
Xuzhou, Jiangsu, China Recruiting -
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China Recruiting -
China-Japan friendship Hospital of Jilin university
Changchun, Jilin, China Recruiting -
The First Hospital of Jilin University
Changchun, Jilin, China Recruiting -
Changda Hospital, Anshan
Anshan, Liaoning, China Recruiting -
Affiliated Zhongshan hospital of Dalian university
Dalian, Liaoning, China Recruiting -
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China Recruiting -
First Hospital of China Medical University
Shenyang, Liaoning, China Recruiting -
Baotou Central Hospital
Baotou, Nei Monggol, China Recruiting -
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China Recruiting -
The People's Hospital of Ningxia
Yinchuan, Ningxia, China Recruiting -
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting -
Shandong Provincial Hospital
Jining, Shandong, China Recruiting -
Qilu Hospital of Shandong University (Qingdao)
Qingdao, Shandong, China Recruiting -
QingDao Municipal Hospital
Qingdao, Shandong, China Recruiting -
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China Recruiting -
The 88th Hospital of PLA
Tai’an, Shandong, China Recruiting -
Shanghai Changzheng Hospital
Huangpu, Shanghai Municipality, China Recruiting
+15 more sites. See ClinicalTrials.gov for the full list.
Study contacts
- Study coordinator: Jianping Jia, Doctor
- Email: jiajp@vip.126.com
- Phone: +8610-83199449
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia
This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.
-
Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s
We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.